The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure. Umbaugh DS, Nguyen NT, Curry SC, Rule JA, et al. Hepatology 2024;79:1352-1364.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Umbaugh DS, Nguyen NT, Curry SC, Rule JA, et al. The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure. Hepatology 2024;79:1352-1364.
PMID: 37910653